Skip to main content
Premium Trial:

Request an Annual Quote

India Readies for Bioinformatics Monsoon


Indian information technology firms have discovered the cash cow of bioinformatics. Lower labor costs mean that establishing facilities, employing scientists and programmers, and handling data are all significantly less expensive in India than in the West, giving the country a new niche. Government officials and industry execs are rushing to form alliances and launch new initiatives in the field.

One of India''s largest IT firms, Satyam, recently announced a five-year agreement with the government-run Center for Cellular and Molecular Biology (CCMB). Satyam will provide the management and marketing structure as well as IT expertise, while CCMB will contribute its research and development capability. The new business unit will market value-added database services and professional manpower to customers involved in genetic research, drug discovery and development, and genetic engineering.

Meanwhile, Indian pharma leader Nicholas Piramal has inked a pact with the government''s Center for Biochemical Technology to pursue functional genomics and bioinformatics in a joint venture called GenoMed. Syngene, an arm of the Indian biotechnology firm Biocon, is involved in custom software and database development, and has plans to go into SNP mining.

The biotech division of DSQ Software is also spinning off its genomics and bioinformatics business. The goal is to develop patentable products, keep the new company debt-free, and get it onto the NASDAQ in 2002. Only a few Indian companies, including Satyam, are listed on the NASDAQ at present. However, the exchange set up an office in Bangalore in February, with plans to list dozens of Indian companies in the next couple of years.

— Sherri Chasin Calvo


The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.